TWiV 767: COVID-19 clinical update #66 with Dr. Daniel Griffin
Jun 12, 2021•40 min•Ep. 767
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #66, Daniel Griffin covers treatment guidelines from IDSA, hospitalization of adolescents, estimating epidemiological dynamics from viral load distributions, incidence of infection according to baseline antibody status, assessment of reinfection in Italy, need for vaccination in previously infected individuals, assessment of protection against reinfection, antimicrobial use in hospitalized patients, effect of single dose ivermectin, and a trial of aspirin in hospitalized patients.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- COVID-19 treatment guidelines (IDSA)
- Hospitalization of adolescents (MMWR)
- Estimating dynamics from viral load (Science)
- Incidence according to antibody status (Lancet)
- Reinfections in Italy (JAMA)
- Need for vaccination in previously infected (medRxiv)
- Assessment of protection against reinfection (ACC)
- Antimicrobial use in hospitalized patients (Lancet)
- Effect of single dose ivermectin (Viruses)
- Aspirin in hospitalized patients (medRxiv)
- Letters read on TWiV 767
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android